Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
4.600
-0.020 (-0.43%)
At close: Oct 6, 2025, 4:00 PM EDT
4.511
-0.089 (-1.94%)
After-hours: Oct 6, 2025, 7:46 PM EDT
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $81.24 million as of October 6, 2025. Its market cap has increased by 100.24% in one year.
Market Cap
81.24M
Enterprise Value
59.33M
1-Year Change
100.24%
Ranking
Category
Stock Price
$4.60
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $81.24M, an increase of 22.19%. That is a compound annual growth rate of 4.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 81.24M | -1.45% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | 66.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |